Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and efficacy of single agent CC-4047
(pomalidomide) in patients with advanced soft tissue sarcomas who have relapsed or are
refractory to prior anticancer therapy.